December 26, 2012 — Covidien announced a definitive agreement to acquire CV Ingenuity. The companies expect to complete the acquisition in the first calendar quarter of 2013. Financial terms of the transaction were not disclosed. CV Ingenuity, a privately held company based in Fremont, Calif., is focused on improving patient outcomes in the treatment of peripheral arterial disease (PAD).

At RSNA 2012, GE Healthcare focused attention on next-generation products and solutions in its computed tomography (CT) and Advantage Workstation (AW) businesses with the announcement of three scanners now available — the Optima CT660 FREEdom Edition, the Optima CT540 and the Discovery CT750 HD FREEdom Edition.


The annual Transcatheter Cardiovascular Therapeutics (TCT) meeting brings many cutting-edge technologies to the forefront during its five days of clinical sessions. This is my editor’s choice of the most innovative technologies discussed during TCT 2012.


A new device about the size of a business card could allow health care providers to test blood for insulin and other blood proteins, cholesterol, and even signs of viral or bacterial infection all at the same time — with one drop of blood. Preliminary tests of the V-chip, created by scientists at The Methodist Hospital Research Institute and MD Anderson Cancer Center, were published by Nature Communications.

Despite earlier signs that a less-invasive surgery is safer and better than “open” operations to repair potentially lethal abdominal aortic aneurysms, a clinical study led by a Johns Hopkins professor shows survival rates after four years are similar for both procedures.

December 21, 2012 — Nanostim Inc. announced the first successful implants of a leadless pacemaker in a series of 11 patients at Homolka Hospital in Prague, Czech Republic. The leadless pacemakers were implanted by Drs. Petr Neuzil, head of cardiology at Homolka Hospital, and Vivek Reddy, director of electrophysiology at Mount Sinai Hospital in New York.

Subscribe Now